TFPI2

TFPI2

Target · Serine protease inhibitor

TFPI2 Tissue factor pathway inhibitor 2 · PP5

TFPI2 (tissue factor pathway inhibitor 2) is a secreted Kunitz-type serine proteinase inhibitor that may help regulate plasmin-mediated matrix remodelling. It is also known as PP5, TFPI-2 and REF1. Browse Assay Genie's current range of TFPI2 research reagents below, or read on for the biology behind the target.

Secreted proteinKunitz-type protease inhibitorTumour suppressor gene
235 aa
Protein length
~27 kDa
Molecular weight
7q21.3
Gene locus
Kunitz-type
Protease inhibitor
Target information

What is TFPI2 (tissue factor pathway inhibitor 2)?

TFPI2 is a serine protease inhibitor that may play a role in the regulation of plasmin-mediated matrix remodelling. According to UniProt, it inhibits trypsin, plasmin and factor VIIa/tissue factor, and inhibits factor Xa only weakly. It has no effect on thrombin. The NCBI Gene summary adds chymotrypsin and plasma kallikrein to the list of serine proteases that the protein can inhibit, so it acts on a range of targets across coagulation and extracellular proteolysis.

The TFPI2 gene encodes a member of the Kunitz-type serine proteinase inhibitor family. The mature protein is secreted, consistent with its activity against extracellular proteases. Alternative splicing of the gene results in multiple transcript variants, which is worth bearing in mind when choosing reagents for a particular region of the protein.

The protein is known by several names, including PP5, TFPI-2 and REF1, and the official name, tissue factor pathway inhibitor 2, reflects its relationship to TFPI, the first tissue factor pathway inhibitor. The TFPI2 gene has been identified as a tumour suppressor gene in several types of cancer, which makes the protein a recurring subject in cancer biology as well as in studies of protease regulation. A mouse ortholog, Tfpi2, is also recognised.

Matrix remodelling research

TFPI2 may regulate plasmin-mediated matrix remodelling, so it is studied in work on extracellular proteolysis.

Coagulation pathway studies

TFPI2 inhibits factor VIIa/tissue factor and weakly inhibits factor Xa, while leaving thrombin unaffected.

Cancer biology

The TFPI2 gene has been identified as a tumour suppressor gene in several types of cancer.

Serine protease inhibition

As a Kunitz-type inhibitor of trypsin, plasmin, chymotrypsin and plasma kallikrein, TFPI2 is used to explore protease specificity.

Background

TFPI2 frequently asked questions

What does TFPI2 do?

TFPI2 is a secreted Kunitz-type serine protease inhibitor. It inhibits trypsin, plasmin and factor VIIa/tissue factor, and weakly inhibits factor Xa, but has no effect on thrombin. It may also play a role in regulating plasmin-mediated matrix remodelling.

What other names does TFPI2 go by, and does it have isoforms?

TFPI2 is also called PP5, TFPI-2 and REF1, and its full name is tissue factor pathway inhibitor 2. Alternative splicing of the gene results in multiple transcript variants, so it is worth checking which region a given reagent targets.

Is TFPI2 linked to disease or conserved in other species?

The TFPI2 gene has been identified as a tumour suppressor gene in several types of cancer. A mouse ortholog, Tfpi2, exists. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Related tissue factor pathway inhibitors and other protease regulators with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P48307; product specifications from Assay Genie datasheets.

TFPI2 Product listing